Search research articles
Contact Us
Filters
Showing results (191-200 of 195) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 195 results.
The Journal of Infectious Diseases
|
May 1, 1978
Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients
R L Perkins, R J Fass, J F Warner, et al.
Journal of Acquired Immune Deficiency Syndromes
|
February 1, 1994
The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3
M A Fischl, L Resnick, R Coombs, et al.
AIDS (London, England)
|
August 16, 2001
A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l
S L Koletar, A E Heald, D Finkelstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2000
Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group
R G Hewitt, C T Yiannoutsos, E S Higgs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 31, 2013
Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)
H Fensterer, C Schade-Brittinger, H-H Müller, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 195) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 195 results.
The Journal of Infectious Diseases
|
May 1, 1978
Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients
R L Perkins, R J Fass, J F Warner, et al.
Journal of Acquired Immune Deficiency Syndromes
|
February 1, 1994
The safety and efficacy of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3
M A Fischl, L Resnick, R Coombs, et al.
AIDS (London, England)
|
August 16, 2001
A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l
S L Koletar, A E Heald, D Finkelstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2000
Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group
R G Hewitt, C T Yiannoutsos, E S Higgs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 31, 2013
Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)
H Fensterer, C Schade-Brittinger, H-H Müller, et al.
Page
of 20